ArticleInternational journal of molecular sciences2021

NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer's Disease.

Yulia K Komleva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.